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Cell cycle molecules are mostly dormant in differentiated
neurons that are post-mitotic and in the G0 state of the cell
cycle. However, a wealth of evidence strongly suggests that in
response to a wide variety of apoptotic stimuli, including
trophic factor deprivation, exposure to β-amyloid (Aβ) and
DNA damage, neurons emerge from theG0 state with aberrant
expression/activation of cell cycle proteins.1 This emergence
is characterized by a consistent set of events related to the cell
cycle that culminate in neuron death. Initial responses include
activation of G1/S cyclin-dependent kinases (Cdks), such as
Cdk4 that in turn phosphorylate retinoblastoma (pRb) family
proteins and lead to dissociation of repressor complexes
comprising E2F and pRb proteins, so that E2F-binding genes
are de-repressed. Among genes that are de-repressed by loss
of E2F-Rb family complexes are the B- and C-myb transcrip-
tion factors that in turn transactivate Bim, a pro-apoptotic
protein that promotes caspase activation and subsequent
neuron death.1–4 This set of events has been termed the
‘apoptotic cell cycle pathway’.
Cell division cycle 25A (Cdc25A), a member of a family
comprisingCdc25A, B andC, is a dual specificity phosphatase
that dephosphorylates inhibitory phosphates on adjacent
threonine and tyrosine residues of Cdks such as Cdk4.5 This
step is essential for initiation of cell cycle in proliferating cells.
However, it was not known whether in the non-dividing
neurons, the same events would activate the apoptotic cell
cycle pathway. In our recent paper published in Cell Death
Discovery,6 we report several novel findings regarding the
potential role of Cdc25A in neuron death. First, Cdc25A is
required for activation of the apoptotic cell cycle pathway and
neuron death in response to nerve growth factor (NGF)
deprivation and Aβ treatment. Second, Cdc25A acts upstream
of Cdk-mediated Rb phosphorylation and caspase-3 clea-
vage. Third, NGF deprivation and Aβ lead to rapid increases in
Cdc25A mRNA and protein levels. NGF withdrawal causes an
increase in Cdc25A activity as well. These events occur at
about the same time that apoptotic insults lead to Cdk4
activation and Rb phosphorylation in our experimental
systems and well precede evident signs of neuron death.
To follow-up on our findings that NGF deprivation and Aβ
induce Cdc25A expression in neurons, we studied the
mechanism by which this occurs. This revealed a pathway in
which NGF deprivation or Aβ treatment leads successively to
Akt inactivation, FoxO activation, and suppression of miR-21
levels with consequent elevation of Cdc25A. Normally, Akt
phosphorylates FoxO transcription factors, which limits them
to the cytosol (Figure 1). Aβ treatment inhibits Akt signalling in
neurons and Akt activity is diminished in brains of AD patients
and of APP transgenic mice.7,8 NGF deprivation also rapidly
decreases Akt phosphorylation/activity.9 When Akt signalling
is suppressed,10 FoxO proteins are dephosphorylated and
translocate to the nucleus where they are transcriptionally
active.3,8,9 We show that FoxO3a downregulates miR-21 (a
microRNA that usually suppresses Cdc25A expression)
thereby upregulating Cdc25A in Aβ-treated neurons.6 More-
over, a miR-21 mimic was sufficient to block Cdc25A mRNA
and protein induction by Aβ. Thus our study places Cdc25A
upstream of Cdk4 activation and subsequent events in the
apoptotic neuronal death pathway and identifies a set of
signaling events by which NGF deprivation or Aβ exposure
regulate cellular Cdc25A levels and activity, leading to neuron
death (Figure 1).
A previous study reported that camptothecin-induced DNA
damage in cultured neurons activates Cdc25A and that
inhibition or knockdown of Cdc25A blocks Cdk4 activation
and Rb phosphorylation as well as cell death, thus linking
Cdc25A to the apoptotic cell cycle pathway.11 However, in
contrast to Aβ or NGF deprivation, camptothecin did not
change Cdc25A levels (and therefore not likely the FoxO-
miR21 pathway), but rather was correlated with loss of activity
of the checkpoint 1 kinase (Chk1).11 Therefore, although it
appears that distal effectors of the neuronal apoptotic cell
cycle pathway are similar for different apoptotic stimuli,
multiple mechanisms may exist to initiate the pathway via
Cdc25A.
Ours is the first report to identify Cdc25A as a required
upstream activator of the apoptotic cell cycle pathway in
trophic factor-deprived neurons and that its levels after Aβ
treatment are elevated by a pathway involving FoxOs and
miR-21.6 In the case of Aβ, our findings are consistent with the
report that neurons in post-mortem brains from AD patients
have elevated Cdc25A levels and that brain tissue from AD
patients has higher Cdc25A phosphatase activity compared to
non-AD brains.12 Also, Kruman et al.13 described a 3–4-fold
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increase in Cdc25A protein in Aβ-treated cortical neuron
cultures. Thus, our study favours a mechanism in which Aβ
elevates Cdc25A expression via FoxO-miR21 signalling and
our data clearly identify Cdc25A as a required player in
Aβ-induced neuron death.
In summary, our study reveals that Cdc25A is elevated,
activated and has an essential role in neuronal cell death
evoked by apoptotic stimuli relevant to normal development and
to AD. Because Cdc25A is an inhibitable enzyme, our study
identifies Cdc25A as a potential target to block pathologic
neuron degeneration and death in AD and other pathologies in
which the neuronal apoptotic cell cycle pathway is activated. In
support of this idea, a selective Cdc25A inhibitor has been
shown to be effective in several non-neuronal experimental
disease models and without reported toxicity.14
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Figure 1 Scheme depicting a molecular pathway by which Cdc25A is induced/activated and promotes neuron death in disease and development. In healthy cells, Akt
phosphorylates FoxO transcription factors and retains them in the cytosol. miR-21, a microRNA that suppresses Cdc25A expression and that is negatively regulated by FoxO3a,
remains elevated in the nucleus to block the apoptotic cell cycle pathway. Aβ treatment and NGF deprivation inhibit neuronal Akt signalling. When Akt signalling is suppressed,
FoxO proteins are activated and translocate to the nucleus. FoxO3a downregulates miR-21 and thereby upregulates Cdc25A. Elevated and activated Cdc25A leads to Cdk4
activation and subsequent Rb phosphorylation, expression of E2F-responsive genes such as B- and C-myb, induction of Bim, caspase activation and neuron death
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